Boehringer Ingelheim Animal Health USA INC.
Animal Health, Medications, Distribution
Based in GA
AI Overview
With $428K in lobbying spend across 21 quarterly filings, Boehringer Ingelheim Animal Health USA INC is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2020 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $68K |
| 2021 | $90K |
| 2022 | $90K |
| 2023 | $90K |
| 2024 | $90K |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Boehringer Ingelheim Animal Health USA INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Agriculture, Animals, Pharmacy
Animal Health
US Vaccine Bank
Vaccine Development
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.